BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 24126800)

  • 1. The role of epithelial mesenchymal transition markers in thyroid carcinoma progression.
    Montemayor-Garcia C; Hardin H; Guo Z; Larrain C; Buehler D; Asioli S; Chen H; Lloyd RV
    Endocr Pathol; 2013 Dec; 24(4):206-12. PubMed ID: 24126800
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunohistochemical detection of epithelialmesenchymal transition associated with stemness phenotype in anaplastic thyroid carcinoma.
    Liu J; Brown RE
    Int J Clin Exp Pathol; 2010 Oct; 3(8):755-62. PubMed ID: 21151388
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ABCG2/BCRP gene expression is related to epithelial-mesenchymal transition inducer genes in a papillary thyroid carcinoma cell line (TPC-1).
    Mato E; González C; Moral A; Pérez JI; Bell O; Lerma E; de Leiva A
    J Mol Endocrinol; 2014 Jun; 52(3):289-300. PubMed ID: 24643400
    [TBL] [Abstract][Full Text] [Related]  

  • 4. E-cadherin adhesion molecule and syndecan-1 expression in various thyroid pathologies.
    Mitselou A; Ioachim E; Peschos D; Charalabopoulos K; Michael M; Agnantis NJ; Vougiouklakis T
    Exp Oncol; 2007 Mar; 29(1):54-60. PubMed ID: 17431390
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunohistochemical analysis of the expression of E-cadherin and ZEB1 in non-small cell lung cancer.
    Matsubara D; Kishaba Y; Yoshimoto T; Sakuma Y; Sakatani T; Tamura T; Endo S; Sugiyama Y; Murakami Y; Niki T
    Pathol Int; 2014 Nov; 64(11):560-8. PubMed ID: 25347933
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of cancer stem cell markers and epithelial-mesenchymal transition-related factors in anaplastic thyroid carcinoma.
    Jung CW; Han KH; Seol H; Park S; Koh JS; Lee SS; Kim MJ; Choi IJ; Myung JK
    Int J Clin Exp Pathol; 2015; 8(1):560-8. PubMed ID: 25755746
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic utility of thyroid transcription factors Pax8 and TTF-2 (FoxE1) in thyroid epithelial neoplasms.
    Nonaka D; Tang Y; Chiriboga L; Rivera M; Ghossein R
    Mod Pathol; 2008 Feb; 21(2):192-200. PubMed ID: 18084247
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of epithelial-mesenchymal transition regulators SNAI2 and TWIST1 in thyroid carcinomas.
    Buehler D; Hardin H; Shan W; Montemayor-Garcia C; Rush PS; Asioli S; Chen H; Lloyd RV
    Mod Pathol; 2013 Jan; 26(1):54-61. PubMed ID: 22899291
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ZEB1 promotes the progression and metastasis of cervical squamous cell carcinoma via the promotion of epithelial-mesenchymal transition.
    Ma Y; Zheng X; Zhou J; Zhang Y; Chen K
    Int J Clin Exp Pathol; 2015; 8(9):11258-67. PubMed ID: 26617850
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in integrin and E-cadherin expression in neoplastic versus normal thyroid tissue.
    Serini G; Trusolino L; Saggiorato E; Cremona O; De Rossi M; Angeli A; Orlandi F; Marchisio PC
    J Natl Cancer Inst; 1996 Apr; 88(7):442-9. PubMed ID: 8618236
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urokinase receptor, MMP-1 and MMP-9 are markers to differentiate prognosis, adenoma and carcinoma in thyroid malignancies.
    Buergy D; Weber T; Maurer GD; Mudduluru G; Medved F; Leupold JH; Brauckhoff M; Post S; Dralle H; Allgayer H
    Int J Cancer; 2009 Aug; 125(4):894-901. PubMed ID: 19480010
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical significance of E-cadherin expression in thyroid neoplasms.
    Naito A; Iwase H; Kuzushima T; Nakamura T; Kobayashi S
    J Surg Oncol; 2001 Mar; 76(3):176-80. PubMed ID: 11276021
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of epithelial-mesenchymal transition regulators TWIST, SLUG and SNAIL in follicular thyroid tumours may relate to widely invasive, poorly differentiated and distant metastasis.
    Wu J; Zhang Y; Cheng R; Gong W; Ding T; Zhai Q; Wang Y; Meng B; Sun B
    Histopathology; 2019 Apr; 74(5):780-791. PubMed ID: 30368884
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ZEB1 expression in type I vs type II endometrial cancers: a marker of aggressive disease.
    Singh M; Spoelstra NS; Jean A; Howe E; Torkko KC; Clark HR; Darling DS; Shroyer KR; Horwitz KB; Broaddus RR; Richer JK
    Mod Pathol; 2008 Jul; 21(7):912-23. PubMed ID: 18487993
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 5'-AMP-Activated Protein Kinase Regulates Papillary (TPC-1 and BCPAP) Thyroid Cancer Cell Survival, Migration, Invasion, and Epithelial-to-Mesenchymal Transition.
    Cazarin JM; Coelho RG; Hecht F; Andrade BM; Carvalho DP
    Thyroid; 2016 Jul; 26(7):933-42. PubMed ID: 27121619
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinicopathological significance of ZEB1 protein in patients with hepatocellular carcinoma.
    Zhou YM; Cao L; Li B; Zhang RX; Sui CJ; Yin ZF; Yang JM
    Ann Surg Oncol; 2012 May; 19(5):1700-6. PubMed ID: 21584833
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Roles of STAT3 and ZEB1 proteins in E-cadherin down-regulation and human colorectal cancer epithelial-mesenchymal transition.
    Xiong H; Hong J; Du W; Lin YW; Ren LL; Wang YC; Su WY; Wang JL; Cui Y; Wang ZH; Fang JY
    J Biol Chem; 2012 Feb; 287(8):5819-32. PubMed ID: 22205702
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of cd56 and e-cadherin expression in the differential diagnosis of papillary thyroid carcinoma and suspected follicular-patterned lesions of the thyroid: the prognostic importance of e-cadherin.
    Ceyran AB; Şenol S; Şimşek BÇ; Sağıroğlu J; Aydın A
    Int J Clin Exp Pathol; 2015; 8(4):3670-80. PubMed ID: 26097548
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Knockdown of BAG3 induces epithelial-mesenchymal transition in thyroid cancer cells through ZEB1 activation.
    Meng X; Kong DH; Li N; Zong ZH; Liu BQ; Du ZX; Guan Y; Cao L; Wang HQ
    Cell Death Dis; 2014 Feb; 5(2):e1092. PubMed ID: 24577090
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Honokiol inhibits epithelial-mesenchymal transition in breast cancer cells by targeting signal transducer and activator of transcription 3/Zeb1/E-cadherin axis.
    Avtanski DB; Nagalingam A; Bonner MY; Arbiser JL; Saxena NK; Sharma D
    Mol Oncol; 2014 May; 8(3):565-80. PubMed ID: 24508063
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.